Home
Conditions
Breast Neoplasms

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,768 public trials 1,787 recruiting studies

Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Not Yet Recruiting

Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for Early-Stage HR-Positive, HER2-Low Breast Cancer

NCT07305246

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

First-Line Sacituzumab Govitecan in Advanced Untreated Triple-Negative Breast Cancer Patients.

NCT07299409

Conditions: Advanced Triple Negative Breast Cancer, Breast Cancer, Breast Cancer Metastatic, +7 more
Locations: BC Cancer - Vancouver Center Vancouver, British Columbia, Canada

View Trial Details

Not Yet Recruiting

An Exploratory Study of Pertuzumab and Trastuzumab in Combination With Palbociclib and Exemestane as Neoadjuvant Therapy for Triple-Positive Breast Cancer

NCT07299890

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

An Exploratory Study on Individualized Neoadjuvant Treatment Regimens for Early HR+/HER2+ Breast Cancer

NCT07300215

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

AST/ALT & MPV/Platelets Ratios in Breast Cancer

NCT07238127

Conditions: AST/ALT Ratio, Breast Cancer, Breast Diseases, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX87in Combination With HLX22 or Pertuzumab in the Neoadjuvant Therapy of HER2-Positive Bresat Cancer

NCT07294534

Conditions: Breast Diseases, Breast Neoplasms, HER2 + Breast Cancer, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase II Study to Evaluate the Efficacy and Safety of Anti-HER2 Triple-targeted Drugs Combined With CDK4/6 Inhibitors in Neoadjuvant Therapy for ER-positive HER2-positive Breast Cancer Patients.

NCT07290166

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Abemaciclib for Molecular Residual Disease Detected by Circulating Tumor DNA in HR+/HER2- Early Breast Cancer

NCT07292207

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: Nagoya City University Nagoya, Japan

View Trial Details

Not Yet Recruiting

FMT in Triple Negative Breast Cancer Guided by ctDNA

NCT07292142

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: London Health Sciences Center London, Ontario, Canada

The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada

Jewish General Hospital Montreal, Quebec, Canada

View Trial Details

Not Yet Recruiting

Effect of Virtual Reality on Pain and Anxiety During Chemotherapy Session in Breast Cancer Patients

NCT07292727

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: Hanaa Hassanin Shehata Sohag, Egypt

View Trial Details

Breast Neoplasms

Breast Neoplasms trial results

Related conditions